Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Nummular headache is a rare type of primary headache in children and adults].
Dunin DN, Morozova EA, Belousova MV, Morozov DV, Prusakov VF, Bogolyubova VV. Dunin DN, et al. Among authors: morozova ea. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(11. Vyp. 2):81-87. doi: 10.17116/jnevro202412411281. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 39576165 Review. Russian.
Universal control of four singlet-triplet qubits.
Zhang X, Morozova E, Rimbach-Russ M, Jirovec D, Hsiao TK, Fariña PC, Wang CA, Oosterhout SD, Sammak A, Scappucci G, Veldhorst M, Vandersypen LMK. Zhang X, et al. Among authors: morozova e. Nat Nanotechnol. 2024 Oct 31. doi: 10.1038/s41565-024-01817-9. Online ahead of print. Nat Nanotechnol. 2024. PMID: 39482413
Smart nanocarriers for enzyme-activated prodrug therapy.
Abo Qoura L, Morozova E, Ramaa СS, Pokrovsky VS. Abo Qoura L, et al. Among authors: morozova e. J Drug Target. 2024 Nov;32(9):1029-1051. doi: 10.1080/1061186X.2024.2383688. Epub 2024 Jul 26. J Drug Target. 2024. PMID: 39045650 Review.
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC).
Niederwieser C, Iacobelli S, Franke GN, Koster L, van Os M, Platzbecker U, Hübel K, Scheid C, Müller LP, Stelljes M, Morozova E, Passweg J, Onida F, Dreger P, Saccardi R, Ladetto M, Salmenniemi U, Bethge W, Poiré X, Kobbe G, McLornan DP, Robin M, Kröger N. Niederwieser C, et al. Among authors: morozova e. Bone Marrow Transplant. 2024 Aug;59(8):1084-1091. doi: 10.1038/s41409-024-02282-7. Epub 2024 Apr 25. Bone Marrow Transplant. 2024. PMID: 38664589 Free PMC article. Clinical Trial.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Onida F, Gras L, Ge J, Koster L, Hamladji RM, Byrne J, Avenoso D, Aljurf M, Robin M, Halaburda K, Passweg J, Salmenniemi U, Sengeloev H, Apperley J, Clark A, Reményi P, Morozova E, Kinsella F, Lenhoff S, Ganser A, Wu KL, Perez-Martinez A, Hayden PJ, Raj K, Drozd-Sokolowska J, OrtÍ G, de Lavallade H, Yakoub-Agha I, McLornan DP, Chalandon Y. Onida F, et al. Among authors: morozova e. Br J Haematol. 2024 Jun;204(6):2365-2377. doi: 10.1111/bjh.19448. Epub 2024 Apr 5. Br J Haematol. 2024. PMID: 38577874
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Brioli A, Lomaia E, Fabisch C, Sacha T, Klamova H, Morozova E, Golos A, Ernst P, Olsson-Stromberg U, Zackova D, Nicolini FE, Bao H, Castagnetti F, Patkowska E, Mayer J, Hirschbühl K, Podgornik H, Paczkowska E, Parry A, Ernst T, Voskanyan A, Szczepanek E, Saussele S, Franke GN, Kiani A, Faber E, Krause S, Casado LF, Lewandowski K, Eder M, Anhut P, Gil J, Südhoff T, Hebart H, Heibl S, Pfirrmann M, Hochhaus A, Lauseker M. Brioli A, et al. Among authors: morozova e. Leukemia. 2024 May;38(5):1072-1080. doi: 10.1038/s41375-024-02204-y. Epub 2024 Mar 28. Leukemia. 2024. PMID: 38548962 Free PMC article.
285 results